Vera Therapeutics Share Price (NASDAQ: VERA)

$21.64

▲

-0.65

(-2.92%)

Last updated on August 30, 2025 at 1:29 am IST

$₹

Check the interactive Vera Therapeutics Stock chart to analyse performance

Vera Therapeutics stock performance

as on August 30, 2025 at 1:29 am IST

Today's Low:$21.22
Today's High:$22.37
$21.64
1.94%
Downside
Day's Volatility :5.12%
Upside
3.24%
52 Weeks Low:$18.53
52 Weeks High:$51.61
$21.64
14.37%
Downside
52 Weeks Volatility :64.1%
Upside
58.07%

Vera Therapeutics Stock Returns

Period	Vera Therapeutics Inc	S&P BSE Consumer Discretionary Goods & Services	Nifty Smallcap 250
3 Months	-31.84%	4.5%	-1.9%
6 Months	-23.85%	18.4%	19.2%
1 Year	-43.6%	-7.5%	-9.2%
3 Years	1.1%	-77.2%	77.8%

Vera Therapeutics Inc Key Stats

Check Vera Therapeutics key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close	$22.29
Open	$22.365
Today's High	$22.365
Today's Low	$21.22
Market Capitalization	$1.4B
Today's Volume	$2.1M
52 Week High	$51.61
52 Week Low	$18.53
Revenue TTM	$0.0
EBITDA	$-235.8M
Earnings Per Share (EPS)	$-3.49
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-54.84%

Stock Returns calculator for Vera Therapeutics Stock including INR - Dollar returns

The Vera Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Vera Therapeutics investment value today

Current value as on today

₹61,697

Returns

₹38,303

(-38.3%)

Returns from Vera Therapeutics Stock

₹43,587 (-43.59%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Vera Therapeutics Stock

-24%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for Vera Therapeutics Stock from India on INDmoney has decreased by -24% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Vera Therapeutics Inc

Name
Holdings %
Name
Holdings %
venBio Select Advisor LLC
9.87%
T. Rowe Price Associates, Inc.
7.02%
BlackRock Inc
6.26%
Kynam Capital Management, LP
5.37%
Deerfield Management Co
5.25%
FMR Inc
5.06%

Analyst Recommendation on Vera Therapeutics Stock

Rating

Trend

Buy

87%Buy

12%Hold

0%Sell

Based on 16 Wall street analysts offering stock ratings for Vera Therapeutics(by analysts ranked 0 to 5 stars)

Vera Therapeutics Share Price Target

What analysts predicted

Upside of 194.59%

Target:

$63.75

Current:

$21.64

Vera Therapeutics share price target is $63.75, a slight Upside of 194.59% compared to current price of $21.64 as per analysts' prediction.

Vera Therapeutics Stock Insights

Price Movement
In the last 7 days, VERA stock has moved down by -4.1%
Price Movement
In the last 6 months, VERA stock has moved down by -3.5%
VERA vs K P R Mill Ltd (1 yr)
In the last 1 year, K P R Mill Ltd has given 16.5% return, outperforming this stock by 41.1%
VERA vs K P R Mill Ltd (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 69.9% return, outperforming this stock by 112.7%
VERA vs Swan Energy Ltd (3 yr)
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 112.6% return, outperforming this stock by 107.1%

Vera Therapeutics Technicals Summary

Sell

Neutral

Buy

Vera Therapeutics is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Vera Therapeutics Inc Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Vera Therapeutics Inc	3.27%	-23.85%	-43.6%	1.1%	55.42%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Vera Therapeutics Inc	NA	NA	NA	-4.21	-0.55	-0.3	NA	7.34

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Vera Therapeutics Inc	Buy	$1.4B	55.42%	NA	0.0%

Vera Therapeutics Dividend announcements

Vera Therapeutics Earnings
Vera Therapeutics’s price-to-earnings ratio stands at None

About Vera Therapeutics Inc

Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on the development and commercialization of transformative treatments for patients with serious immunological diseases. The company's lead product candidate consists of atacicept, a fully humanized TACI-Fc fusion protein that binds B-cell activating factor (BAFF) and A proliferation-inducing ligand (APRIL), which is self-administered at home as a subcutaneous injection being evaluated for the treatment of immunoglobulin A nephropathy (IgAN). It is also developing MAU868, a human monoclonal antibody for the treatment of BK viremia infections that has completed phase 2 clinical trial; and VT-109, a novel BAFF/APRIL dual-inhibitor B cell maturation antigen (BCMA) molecule to treat B cell mediated autoimmune diseases. The company was formerly known as Trucode Gene Repair, Inc. and changed its name to Vera Therapeutics, Inc. in April 2020. Vera Therapeutics, Inc. was incorporated in 2016 and is headquartered in Brisbane, California.

Organization	Vera Therapeutics
Employees	192
CEO	Dr. Marshall W. Fordyce M.D.
Industry	Services

Key Management of Vera Therapeutics Inc

Name	Title
Dr. Marshall W. Fordyce M.D.	Founder, President, CEO & Director
Mr. Jason S. Carter	Chief Legal Officer
Dr. Robert M. Brenner M.D.	Chief Medical Officer
Mr. Sean P. Grant M.B.A.	Chief Financial Officer
Mr. David L. Johnson M.B.A.	Chief Opearating Officer
Mr. Joseph R. Young M.B.A.	Senior VP of Finance & Chief Accounting Officer
Dr. Allen Ebens B.Sc., Ph.D.	Executive Vice President of Research
Ms. S. Sandra Park J.D.	Senior VP of Legal, Healthcare,Commercial Law, Compliance & Operations
Ms. Debra Charlesworth	Vice President of Corporate Communications
Ms. Emma Haywood	Vice President of Marketing

Important FAQs about investing in VERA Stock from India :

What is Vera Therapeutics share price today?

Vera Therapeutics share price today is $21.64 as on August 30, 2025 at 1:29 am IST at the close of the market. Vera Therapeutics share today touched a day high of $22.37 and a low of $21.22.

What is the 52 week high and 52 week low for Vera Therapeutics share?

Vera Therapeutics share touched a 52 week high of $51.61 and a 52 week low of $18.53. Vera Therapeutics stock price today i.e. August 30, 2025 at 1:29 am IST is closed at $21.64, lower by 58.07% versus the 52 week high.

How to invest in Vera Therapeutics Stock (VERA) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Vera Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Vera Therapeutics Shares that will get you 0.0693 shares as per Vera Therapeutics share price of $21.64 per share as on August 30, 2025 at 1:29 am IST.

What is the minimum amount required to buy Vera Therapeutics Stock (VERA) from India?

Indian investors can start investing in Vera Therapeutics (VERA) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Vera Therapeutics stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on Vera Therapeutics share’s latest price of $21.64 as on August 30, 2025 at 1:29 am IST, you will get 0.4621 shares of Vera Therapeutics. Learn more about fractional shares .

What are the returns that Vera Therapeutics has given to Indian investors in the last 5 years?

Vera Therapeutics stock has given 55.42% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?